# Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells

> **NCT03755297** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 27 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Blood sample analysis of patients treated as standard care

## Key facts

- **NCT ID:** NCT03755297
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-12
- **Primary completion:** 2022-08-12
- **Final completion:** 2022-11-12
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Default of recruitment
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755297, "Effect of the Inhibitors of the Way JAK-STAT on Regulatory B Cells". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03755297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*